Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.

Guerra-García PilarSimon BomkenRebecca LingArina LazarevaGirish L GuptePersis AmroliaMara AndrésJesús Diez-SebastiánMary M Taj

Published in: Pediatric blood & cancer (2024)

R-COP provides an effective low-dose chemotherapy option. Escalation to more intensive therapies in the minority of inadequately controlled patients is an effective strategy.

Keyphrases

low dose
end stage renal disease
chronic kidney disease
ejection fraction
emergency department
intensive care unit
clinical trial
epstein barr virus
prognostic factors
high dose
locally advanced
open label
patient reported outcomes
double blind
combination therapy
patient reported